Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
NCT01818713
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Meningeal Carcinomatosis
Interventions
DRUG:
2B3-101
Sponsor
The Netherlands Cancer Institute